tirzepatide with b6 reddit Questions about B-6 additive, injection location, & initial dosages. : r/tirzepatidecompound tirzepatidecompound

10 in stock (can be backordered) Tirzepatide is a dual GIP/GLP-1 receptor agonist (twincretin) developed by Eli Lilly and approved by the FDA in 2022 for type 2 diabetes (Mounjaro) and in 2023 for obesity (Zepbound)

GLP-1, or glucagon-like peptide-1, is a hormone that plays a major role in appetite regulation, digestion, and insulin release through a process called the incretin effect (1)

Current Candidates for Tirzepatide Because tirzepatide is accessible right now, it is the primary consideration for: Individuals requiring immediate intervention for class II or class III obesity

Adapted from Kadowaki et al

If injection reactions are a deal-breaker, discuss non-injectable options such as Motus (oral) with your clinician